A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
| Image |  |
|---|---|
| Description | scientific article published on 14 May 2020 |
| Author/s |
author: Lillian Siu |
| Publication date | May 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |